GITNUX MARKETDATA
Browse Our Category
Health Medicine
Latest update:
Child Death Statistics
Child deaths under 5 fell from 2019 to 2020 in the global count, but the WHO and UNICEF excess mortality estimates show the pandemic still pushed survival in the wrong direction. You will see how newborn timing, preventable infections like pneumonia and diarrhoea, and household air pollution and unsafe water together drive the scale, alongside where lifesaving fixes such as bed nets, early breastfeeding, and measles vaccination coverage are making the biggest difference.
Smoking Death Statistics
Smoking drives about 1 in 10 deaths worldwide and in the US it still claims 20% of premature deaths, yet quitting before age 40 cuts the risk of smoking related death by about 90%. Track the latest prevalence, market, and tax signals alongside the disease risks like COPD to see how tobacco turns consumption into lasting loss of life.
Depressants Statistics
Depressants charts the gap between how common depression is and how unevenly treatment reaches people, with 4.4% of U.S. adults reporting depression treatment in 2022 alongside worldwide depression affecting 5.0%. It also pulls together what works and what it costs, from effect sizes like antidepressants reducing symptom severity by about -0.31 to therapies such as high intensity CBT priced around £20,000 to £30,000 per QALY, plus the market trajectory that is forecast to keep accelerating.
Body Statistics
Measured obesity affects 18.5% of U.S. adults in 2023, while 41.9% report measured obesity prevalence and weight related concerns are cited by 51.3% of Americans. You will also see how kidney disease and diabetes fit into the same picture, alongside treatment and cost signals that help explain why markets for fitness, digital health, and GLP 1 options are accelerating.
Pressure Ulcers In Nursing Homes Statistics
With CMS MDS reporting 3.4% of long stay residents having pressure ulcers documented, while international studies often show far higher prevalence, this page pinpoints why the risk keeps looking inconsistent across settings. It also ties prevention wins like a 23% reduction from scheduled repositioning to the staffing, mobility, cognition, and costing pressures that make pressure injury prevention so difficult to sustain in nursing homes.
Opioids Statistics
Fentanyl was involved in 82% of U.S. opioid-involved overdose deaths in 2023, even as only a minority of people with opioid use disorder received medication for it. Get the latest snapshots of misuse, treatment coverage, and the cost of opioid harm, alongside market and spending figures that show how prevention and services are stacking up against the crisis.
Covid Statistics
Hospitalized COVID-19 case fatality sat around 20% in early waves, while by late 2020–2021 prophylactic anticoagulation and Paxlovid were linked to major reductions in serious outcomes, including an associated 89% drop in hospitalization or death. You will also see how variant shifts, timing to recovery, and ICU and persistent symptom rates fit together with system level impacts and policy context, right down to what dosing changes did to Omicron BA.4 and BA.5 protection.
Benzodiazepine Prescription Statistics
With 2.5% of U.S. adults receiving a benzodiazepine prescription in 2020 and 9.4% of sedative-involved overdose deaths implicating benzodiazepines, the pattern is more consequential than most people expect. This page ties prescribing and persistence to overdose and older adult harms, including a 1.5x higher hip fracture risk and 30 to 50% deprescribing reductions, while showing where policy tools like PDMPs and structured taper plans can change outcomes.
Heroin Recovery Statistics
Even with 81,043 opioid overdose deaths in 2022, people leaving opioid treatment who receive MOUD face far lower overdose risk, while coverage is still uneven with only 22% of adults with opioid use disorder receiving medications for opioid use disorder in 2023. This page puts heroin recovery in focus by connecting evidence based treatments like methadone, buprenorphine, and relapse preventing naltrexone with real world outcomes such as naloxone distribution and take home harm reduction, so you can see what works and what still needs to reach more people.
Consumer Health Industry Statistics
From OTC access and affordability to quality and recalls, this page tracks what is driving consumer health behavior and spending, including $255B in 2023 OTC revenue and $420.2B in 2023 dietary supplement growth. It also maps the digital shift behind purchases with 23x telehealth adoption and 1.1 billion global consumer health app downloads alongside the tension between rising check the label habits and persistent quality red flags.
National Health Statistics
With 36% of U.S. healthcare organizations reporting AI pilots or implementation in 2024 alongside growing cybersecurity pressure, this National Health statistics page ties together the numbers behind care quality, digital access, and the real risks patients face. Track how common conditions and gaps in access and coverage coexist with rising costs and workforce realities, from hypertension to uninsured rates and ransomware headlines.
Male Hair Loss Statistics
More than 1 in 5 men in the United States live with androgenetic alopecia, which accounts for about 95% of male hair loss and can begin as early as before age 30 in 2.5–7.1% of cases, yet most treatment patterns are far messier than the science. Find how Norwood Hamilton stages and Sinclair I through VII are used alongside trial results and real world use rates, including a 54% finasteride discontinuation within 1 year and how finasteride, microneedling plus minoxidil, and low level laser therapy compare on hair counts and tolerability.
Hearing Aid Statistics
Hearing help adoption still sits at about 33% globally, even as modern hearing aids, evidence-backed outcomes, and faster market momentum push the hearing aid industry toward a projected $14.8 billion by 2030. You will also see how regulations, pricing, and real-world gains like improved speech in noise and cognitive risk reduction collide with access barriers such as cost limits in the US.
Professional Sports Injuries Statistics
Professional Sports Injuries pinpoints the real scale of risk, from 3.7 million youth injuries each year to 10.5% of pro soccer players getting hurt during training exposures, and shows why workload spikes and sprint intensity can flip risk fast. You will also see how concussion and recovery timelines, imaging and rehab patterns, and prevention programs like neuromuscular training shift outcomes, alongside the costs and market pressures reshaping how teams and clinicians respond.
Longevity Statistics
Healthcare is a staggering $3.6% of global GDP in low income countries versus 15.3% in the United States and 14.8% in France, yet the funding for the longevity pipeline is smaller than most people expect with just 8.0% of health spending going to health R and D in 2021. See how the mix of long term care costs, survival gains, and emerging tech markets like AI in healthcare and digital therapeutics helps explain both the opportunity and the bottlenecks for living longer with better health.
Interesting Medical Statistics
Your body runs on mind boggling numbers and you will see them side by side, from 300 to 500 million alveoli and a brain power draw of 12 to 25 watts to skin that renews every 27 days and a heart that beats about 100,000 times each day. Then the page pivots to what those limits mean for survival, with heart disease still responsible for 17.9 million deaths annually and diabetes affecting 422 million adults, plus a timeline of breakthrough medical tech that reshaped care from vaccines to CRISPR.
Opioid Statistics
US funding for opioid response climbed from $2.0 billion in FY2022 to $2.3 billion in FY2023 and $2.8 billion in FY2024, even as 1.9 million patients still received opioid pain relievers for non-cancer pain in 2020. You will also see the sharp gaps behind treatment and prevention, including that only 28.1% of adults with opioid use disorder got any substance use treatment in 2022, alongside gains like a 90% rise in naloxone prescribing in Medicare Part D from 2013 to 2019.
Meth Relapse Statistics
Even when treatment works, meth relapse remains stubbornly common with about half of people with substance use disorders relapsing within a year and cravings showing up in 80.0% of relapse episodes. This page pulls together the most actionable risk and prevention signals, including contingency management and integrated approaches, plus what high-frequency monitoring and relapse prevention therapy can change.
Drug Relapse Statistics
When treatment ends, relapse is not a slow drift but a fast rebound, with 40% to 60% of people with substance use disorders relapsing after treatment and opioid return-to-use risk spiking sharply when MOUD is discontinued. This page puts the timeline in context so you can see why staying in care and using the right medication and supports can mean the difference between months of risk and long term recovery.
Obesity Statistics
Obesity affects 1.3 billion people worldwide and is linked to millions of deaths, with the global burden now costing about $2.0 trillion each year by 2020. You will also see how risks and spending translate into real life, from US obesity rising to 41.9% in 2017–2018 to treatments like semaglutide and tirzepatide delivering double digit weight loss in major trials.